Enzymes and proteins involved in lysine acetylation are deregulated in cancer.
KATs KDACs and bromodomain proteins may act as oncoproteins or tumor suppressors.
A strategy for in depth characterization of lysine acetylation is proposed.
Stoichiometry of acetylation can be determined by isotopic labeling and MS analysis.